{"news_desk": "Business", "print_page": "2", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By CHAD BRAY", "person": [{"rank": 1, "role": "reported", "firstname": "Chad", "organization": "", "lastname": "BRAY"}]}, "abstract": "Alvogen announces that CVC Capital Partners-led consortium of investors will acquire controlling stake in company, in deal that values Alvogen at around $2 billion including its debt.", "type_of_material": "News", "word_count": "213", "lead_paragraph": "The consortium, which includes Vatera Healthcare Partners and Temasek Holdings, will acquire a controlling stake in the New Jersey-based drug maker.", "pub_date": "2015-06-23T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "CVC Capital and Investment Partners Acquire Stake in Alvogen", "print_headline": "Business Briefing; Investor Group Takes Control of Drug Maker Alvogen"}, "snippet": "The consortium, which includes Vatera Healthcare Partners and Temasek Holdings, will acquire a controlling stake in the New Jersey-based drug maker.", "multimedia": [], "web_url": "http://www.nytimes.com/2015/06/23/business/dealbook/cvc-capital-and-investment-partners-acquire-stake-in-alvogen.html", "keywords": [{"rank": "2", "is_major": "Y", "value": "CVC Capital Partners", "name": "organizations"}, {"rank": "3", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Temasek Holdings", "name": "organizations"}, {"rank": "6", "is_major": "N", "value": "New Jersey", "name": "glocations"}, {"rank": "7", "is_major": "N", "value": "Alvogen Inc", "name": "organizations"}], "blog": [], "_id": "5587f8a538f0d810c23642b5", "source": "The New York Times"}